Skip to main content
VENTURE LIFE GROUP PLC logo

VENTURE LIFE GROUP PLC — Investor Relations & Filings

Ticker · VLG ISIN · GB00BFPM8908 LEI · 213800S8CZUPLAB2KC70 IL Manufacturing
Open in API
Filings indexed 437 across all filing types
Latest filing 2022-12-01 Regulatory Filings
Country GB United Kingdom
Listing IL VLG

About VENTURE LIFE GROUP PLC

https://www.venture-life.com/

Venture Life Group PLC is a consumer self-care company that develops, manufactures, and distributes products for the global market. The company focuses on non-prescription items that consumers can purchase directly, addressing preventative wellness and quality of life issues, particularly those related to an aging population. Its product portfolio encompasses a range of categories, including medical devices, food supplements, dermo-cosmetics, and oral healthcare. Venture Life manages the entire product lifecycle, from initial concept and in-house manufacturing to international commercialization through a network of global partners.

Recent filings

Filing Released Lang Actions
Acquisition and trading update
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and is dated '01 December 2022'. It announces a significant corporate action: the acquisition of three ENT brands via the purchase of HL Healthcare Limited for £13.0 million. It also includes a trading update regarding new distribution agreements. The presence of the RNS header, the announcement of a material event (acquisition), and the closing statement referencing RNS, the London Stock Exchange, and the FCA strongly indicate this is a regulatory news service announcement. Since it details a major corporate transaction (M&A activity) and provides operational updates, it fits best under the general Regulatory Filings category (RNS) or potentially M&A Activity (TAR). However, RNS is the most accurate classification for documents explicitly distributed via the RNS system detailing corporate news that isn't a formal statutory report (like 10-K or IR). Given the content is an acquisition announcement, TAR is also plausible, but RNS covers the distribution mechanism and general corporate news announcements.
2022-12-01 English
Directorate Changes
Board/Management Information Classification · 100% confidence The document begins with 'RNS Number : 2575C' and is dated '10 October 2022'. The content explicitly announces 'Directorate Changes', specifically the appointment of Mr Mark Adams as Non-Executive Director and the stepping down of Mr Peter Bream. This directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS, the core subject matter is management change, making MANG the most specific classification.
2022-10-10 English
Investor Presentation
Report Publication Announcement Classification · 99% confidence The document explicitly states: 'VENTURE LIFE GROUP PLC... Investor Presentation'. It further details that management will provide a 'live presentation of the interim results for the six months ended 30 June 2022 via the Investor Meet Company platform'. This content directly matches the definition of an Investor Presentation (IP), which is a detailed presentation for investors focusing on financials and strategy. Although it relates to interim results, the primary purpose described is the presentation itself, not the comprehensive financial report (IR) or the initial earnings release (ER). The document is short and serves as an announcement for this presentation event.
2022-09-23 English
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is an 'Unaudited interim results' report for the six months ended 30 June 2022. It contains detailed financial highlights, commercial highlights, management commentary (CEO and Chair statements), and operational reviews. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-09-22 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document explicitly announces a transaction involving the purchase of ordinary shares by a Non-Executive Chairman, Paul Mcgreevy. It details the price, volume, date (25 July 2022), and includes disclosures required under Article 19(3) of the Market Abuse Regulation concerning transactions by persons discharging managerial responsibilities (PDMRs). This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The RNS Number and the format confirm it is a regulatory announcement, but the specific content points to 'DIRS'.
2022-07-25 English
Trading Update
Earnings Release Classification · 100% confidence The document is titled 'Trading Update' and provides key financial highlights (revenues, margins, net debt) for the six months ended 30 June 2022. It explicitly states that the Group expects to release 'interim results in September'. This content—a summary of performance for a period shorter than a year, released before the full interim report—is characteristic of an Earnings Release (ER). It is not the comprehensive Interim/Quarterly Report (IR) itself, nor is it a full transcript (CT) or an Annual Report (10-K). The presence of the RNS header confirms it is a regulatory announcement, but the specific content points directly to ER. H1 2022
2022-07-25 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.